Investor Relations

Advanced therapies for the sports medicine and severe burn care markets

Investor Relations

SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Sep 24, 2014
Document Date
Sep 16, 2014
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Vericel Corporation
Issuer
VERICEL CORP
Filer
BLUTT MITCHELL J MD

Day High:
Day Low:
Volume:
on
Data Provided by Refinitiv. Minimum 15 minutes delayed.